These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9411361

  • 1. [Primary malignant non-Hodgkin's lymphomas of the central nervous system in immunocompetent patients: diagnostic, prognostic and therapeutic criteria].
    Ferracini R.
    Pathologica; 1997 Apr; 89(2):146-54. PubMed ID: 9411361
    [Abstract] [Full Text] [Related]

  • 2. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 3. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.
    Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036
    [Abstract] [Full Text] [Related]

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 5. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 15; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 6. [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].
    Blay JY.
    Bull Cancer; 1997 Oct 15; 84(10):976-80. PubMed ID: 9435800
    [Abstract] [Full Text] [Related]

  • 7. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
    Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A.
    Cancer; 2007 Oct 15; 110(8):1803-14. PubMed ID: 17721992
    [Abstract] [Full Text] [Related]

  • 8. [T-type primary lymphoma of the central nervous system in immunocompetent patients].
    Barrena-Caballo MR, Blanch-Labrador M, Giménez-Mas JA, Alberdi-Viñas J, Pascual-Piazuelo M, Zubiri-Ara L.
    Rev Neurol; 2007 Oct 15; 36(2):125-30. PubMed ID: 12589598
    [Abstract] [Full Text] [Related]

  • 9. Treatment of AIDS-related lymphomas.
    Sparano JA.
    Curr Opin Oncol; 1995 Sep 15; 7(5):442-9. PubMed ID: 8541390
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 Sep 15; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 11. [Primary central nervous system lymphomas].
    Hrudková M, Belada D, Smolej L, Zák P, Malý J.
    Vnitr Lek; 2010 Aug 15; 56(8):795-800. PubMed ID: 20845611
    [Abstract] [Full Text] [Related]

  • 12. Primary CNS lymphoma.
    Gerstner E, Batchelor T.
    Expert Rev Anticancer Ther; 2007 May 15; 7(5):689-700. PubMed ID: 17492932
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P, Giglio P.
    Hematol Oncol Clin North Am; 2005 Aug 15; 19(4):597-609, v. PubMed ID: 16083825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
    Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE.
    Cancer; 2008 Sep 01; 113(5):1025-31. PubMed ID: 18618509
    [Abstract] [Full Text] [Related]

  • 18. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ, Assanelli A, Crocchiolo R, Ciceri F.
    Hematol Oncol; 2009 Jun 01; 27(2):61-70. PubMed ID: 19247977
    [Abstract] [Full Text] [Related]

  • 19. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
    Daum S, Ullrich R, Heise W, Dederke B, Foss HD, Stein H, Thiel E, Zeitz M, Riecken EO.
    J Clin Oncol; 2003 Jul 15; 21(14):2740-6. PubMed ID: 12860953
    [Abstract] [Full Text] [Related]

  • 20. Low-grade primary central nervous system lymphoma in immunocompetent patients.
    Jahnke K, Thiel E, Schilling A, Herrlinger U, Weller M, Coupland SE, Krümpelmann U, Stein H, Korfel A.
    Br J Haematol; 2005 Mar 15; 128(5):616-24. PubMed ID: 15725082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.